NCT05032183 2025-08-11Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaM.D. Anderson Cancer CenterPhase 1/2 Terminated4 enrolled 8 charts